Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis

Acta Haematol. 2023;146(6):543-546. doi: 10.1159/000524630. Epub 2022 May 2.

Abstract

Bleeding complications in patients with myeloproliferative neoplasms are known to be related to acquired von Willebrand disease or platelet dysfunction. Here, we describe two very similar cases of chronic phase chronic myeloid leukemia with extreme leukocytosis (>500,000/mcL) and deep tissue bleeding after a minor trauma, who had increased PT and PTT, normal VWF antigen and activity. The patients were found to have acquired factor V deficiency. Factor V deficiency as a cause of bleeding in patients with uncontrolled chronic myeloid leukemia has not yet been reported. Bleeding resolved after correction of hyperleukocytosis, and FV level improved. We conclude that acquired FV deficiency is possible in patients with uncontrolled chronic myeloid leukemia and extreme leukocytosis.

Keywords: Acquired factor V deficiency; Acquired factor XI deficiency; Acquired prothrombin deficiency; Bleeding disorders; Chronic myeloid leukemia; Megakaryocytes.

Publication types

  • Case Reports

MeSH terms

  • Factor V Deficiency* / complications
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukocytosis / etiology
  • von Willebrand Diseases*
  • von Willebrand Factor

Substances

  • von Willebrand Factor